François ANGER

Chairman
Haematology
ADDMEDICA
Hungary

Academician Haematology
Biography

François Anger is a president and owner of addmedica

Research Intrest

In hematology, the company holds the European Marketing Approval of the sole drug indicated in a rare disease called Sickle Cell Disease. In the domain of organ grafts, it distributed in France the best fitted preservation solution for pulmonary grafts, as well as an experimental solution designed to assess the functionality of the lung before transplantation. Lastly, in the domain of wound healing, it commercializes a range of high technology products, mainly for hospital use.